Financials

Discussions Technicals Seasonals

225220 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

GENOLUTION, Inc. engages in the research and development of nucleic acid extractors. It operates through the Vitro Diagnostic and RNAi business divisions. The company was founded on February 20, 2006 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

225220 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company